share_log
Breakings ·  Dec 3, 2024 17:00
Immunocore Announces Reimbursement Agreement in England for Kimmtrak▼ for the Treatment of Hla-a*02:01-Positive Adults With Unresectable or Metastatic Uveal Melanoma
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment